LGALS9 and lung carcinoma: Follow-up experiments in syngeneic mice bearing CT26 colon or LLC lung carcinomas confirmed afatinib-dependent Gal-9 upregulation not only in tumor cells but also in tumor-infiltrating macrophages, DCs, neutrophils, or monocytes.